Vantage Investment Partners’s ProPhase Labs PRPH Stock Holding History

Vantage Investment Partners’s Portfolio PRPH Stock Details PRPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-43,334	Closed	-$927K	–	82
2017 Q3	$927K	Hold	43,334	–	–	0.07%	61
2017 Q2	$906K	Hold	43,334	–	–	0.08%	58
2017 Q1	$984K	Hold	43,334	–	–	0.11%	54
2016 Q4	$867K	Hold	43,334	–	–	0.12%	45
2016 Q3	$854K	Sell	43,334 -458	-1%	-$7.86K	0.11%	53
2016 Q2	$573K	Hold	43,792	–	–	0.06%	61
2016 Q1	$613K	Hold	43,792	–	–	0.07%	66
2015 Q4	$656K	Hold	43,792	–	–	0.1%	58
2015 Q3	$727K	Hold	43,792	–	–	0.13%	55
2015 Q2	$591K	Hold	43,792	–	–	0.16%	55
2015 Q1	$574K	Hold	43,792	–	–	0.25%	38
2014 Q4	$639K	Hold	43,792	–	–	0.19%	39
2014 Q3	$613K	Hold	43,792	–	–	0.2%	37
2014 Q2	$740K	Hold	43,792	–	–	0.22%	35
2014 Q1	$876K	Hold	43,792	–	–	0.28%	34
2013 Q4	$705K	Hold	43,792	–	–	0.23%	37
2013 Q3	$832K	Hold	43,792	–	–	0.26%	37
2013 Q2	$679K	Buy	+43,792	New	+$682K	0.23%	37

Other funds holding PRPH

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vantage Investment Partners's PRPH Position: Q4 2017 in Review

Vantage Investment Partners sold out of ProPhase Labs (PRPH) in Q4 2017, closing a stake of 43,334 shares — an estimated $927K sold.

Vantage Investment Partners first reported a position in PRPH in Q2 2013 and held it in 18 quarters. The position peaked at $984K in Q1 2017. 12 funds tracked by Wall St. Rank hold PRPH as of Q4 2017.

Vantage Investment Partners reported no remaining ProPhase Labs position as of Q4 2017 after selling out during the quarter.
Vantage Investment Partners sold 43,334 ProPhase Labs shares in Q4 2017, an estimated $927K.
Vantage Investment Partners first reported a position in ProPhase Labs in Q2 2013 and held it in 18 quarters.
Vantage Investment Partners's ProPhase Labs position peaked at $984K in Q1 2017.
12 funds tracked by Wall St. Rank held ProPhase Labs as of Q4 2017.

Based on Vantage Investment Partners's 13F filing for Q4 2017, filed 14 Feb 2018.